TRPC6 Knockout Alleviates Renal Fibrosis through PI3K/AKT/GSK3B Pathway

A randomized clinical study demonstrates that the Jianpi Shengxue tablet effectively treats #RenalAnemia by significantly improving red blood cell counts, iron metabolism markers, and systemic symptoms compared to standard #IronTherapy. #Medsky

Read more: doi.org/10.1007/s115...

This study shows that Jianpi Shengxue tablets are effective for #RenalAnemia in #CKD patients, significantly improving #IronMetabolism, relieving #Anemia symptoms, & enhancing nutritional status, promising advances in integrative #KidneyCare. #medsky

See: link.springer.com/article/10.1...